The increasing awareness of the scientific research community on the importance of open access and openscience has given rise to a new funding...

While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of...

Computational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug...

Last year, Scientist announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases. We know how...

We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...

Collaborative Drug Discovery (CDD) is hosting their users and community meeting at the UCSF Mission Bay Conference Center in San Francisco on...

If you hobnob around scientists, you might be increasingly hearing the mysterious acronym “CRISPR” being mentioned in conversation. CRISPR...

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Published in The Coast News last week, was a great article about how Bio, Tech and Beyond, the darling incubator lab of San Diego, is providing...

Most people have probably heard of Alexander Fleming’s chance encounter with a penicillin-producing fungus. What is not quite well-known is that...